RWJBarnabas and RCINJ Strengthening Investments in Cancer Research and Care
On Nov 9, 2023
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey are making transformative investments to conquer cancer through groundbreaking research and personalized, patient care. By investing in state-of-the-art facilities, translational research, sophisticated technologies and nationally recognized faculty, physicians and staff, the organizations’ ventures will strengthen their collective work to reimagine cancer prevention, diagnosis and treatment.
The two institutions have highlighted the following investments:
An integrated network of comprehensive cancer research and care, bringing new, state-of-the-art facilities close to home for patients across the region. Projects underway include:
New Jersey’s first free-standing cancer hospital: The Jack and Sheryl Morris Cancer Center in New Brunswick – a $750 million investment where patients will have access to advanced clinical research, cancer treatments and oncology support services.
The Cancer Center at Cooperman Barnabas Medical Center in Livingston – a $225 million outpatient center that will be a regional hub for integrated cancer services.
The Vogel Medical Campus at Tinton Falls – a $200 million outpatient center in Monmouth County that will include comprehensive cancer services, same-day surgery, on-site specialty services and advanced diagnostic imaging.
The recruitment and retention of world-class clinical and academic leaders to expand their research portfolio and train the next generation of clinicians.
Expanded clinical research programs and collaborations, such as:
The Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, which will lead the development of new therapies for patients and allow researchers to test new interventions.
The Ludwig Princeton Branch of the Ludwig Institute for Cancer Research at Princeton University, which is dedicated to the study of cancer metabolism and the translation of discoveries into clinical trials and novel therapies for patients.
Increased access to care and advanced treatment options, like precision medicine, immunotherapy, CAR T-Cell therapy, bone and marrow transplantation, complex surgical procedures and sophisticated radiation therapy techniques, many not widely available elsewhere.
Enhanced patient and family experiences, powered by an oncology nurse navigation program and holistic wellness resources, to ensure physical and emotional health throughout the cancer journey.
In addition to investments made by both organizations, these efforts are made possible by the generosity of families, foundations and community partners.
“We are at an inflection point in cancer. Our joint investment of resources, expertise and compassion means we’ll continue to provide our patients and their families with the care and support they won’t find anywhere else,” said Steven K. Libutti, MD, FACS, director of Rutgers Cancer Institute of New Jersey and senior vice president of oncology services, RWJBarnabas Health. “Through the research and clinical power of the state’s only National Cancer Institute-designated Comprehensive Cancer Center, including our NCI Consortium Cancer Center partner, Princeton University, and the healthcare delivery power of the state’s largest academic health system, we will reimagine what a cancer diagnosis means and chart a new path for patients on their journeys to survivorship.”
“Through our partnership, RWJBarnabas Health and Rutgers Cancer Institute are translating groundbreaking research into exceptional cancer care for communities across New Jersey,” said Mark E. Manigan, President and CEO for RWJBarnabas Health. “Together, we’re providing patients with access to a world-class network of physicians, clinical trials and ancillary services that are transforming the prevention, diagnosis and treatment of cancer in New Jersey and beyond.”